CHEK1 and breast cancer: Our previous studies have shown that CPX can inhibit cell proliferation and apoptosis in rhabdomyosarcoma (Rh30) and breast cancer (MDA-MB-231) cells [10]; meanwhile, CPX can induce DNA damage, which activates the ATR-Chk1 DDR pathway [21].